Expression of Follistatin, Activin A and BMP-4 in Rats with Hypoxic-Ischemic Brain Damage

TIAN An-hao, ZHAO Wei, ZHANG Lei. et al

Abstract

To investigate the expression and significance of follistatin, activin A and bone morphogenetic protein-4 (BMP-4) in normal brain tissues of rats and the brain tissues with hypoxic and ischemicgin. Methods Sixty conception SD rats were divided into normal and model group (with 30 for each). According to the development of fetal rats in each group, they were randomly divided into six subgroups (embryonic stage 8.5 d, 13 d, 18 d (E8.5,E13,E18), and after the birth 3 d, 7 d and 30 d (P3,P7,P30), five fetal or young rats in each subgroup. Hypoxic-ischemic brain model was established. Expressions and origins of follistatin, activin A and BMP-4 with hypoxic-ischemic brain damage were determined by immunohistochemical and RT-PCR methods. Results In normal group, follistatin and activin A protein expressed at a very low level and gradually decreased with the period of fetal development when evaluated with immunohistochemical and RT-PCR methods; almost no expression of BMP-4 was detected in embryonic but a little bit of expression at 30 d after the birth. In hypoxic-ischemic brain damage group, the expression of follistatin, activin A and BMP-4 was significantly higher than those in normal group (P<0.01). Conclusion The expression of Follistatin, activin A and BMP-4 are related to developmental time, the expression of follistatin, activin A and BMP-4 is highly increased after cerebral ischemia and hypoxia injury. This implies that the main function of follistatin is as the inhibitor of activin A instead of the ligland of BMP-4 to regulate neural development.

 

Keywords:  Rat. Hypoxia-ischemia, Brain, Follistatin, Activin A BMP-4 

 

Full Text:

PDF


References


Chen YG. Wang Q. Lin SL. et al. Activin singnaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp Biol Med ( Maywood), 2006; 231 ( 5) ; 534- 544.

Chang H, Brown CW, Matzuk M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev,2002;23(6):787-823.

Chacko BM, Qin BY, Tiwari A, et al. Structural basis of heteromeric smad protein assembly in TGF-beta singaling. Mol Cell,2004 ; 15(5) :813-823.

Tsuchida K. Nakatani M, Uezumi A,et al. Signal transduction pathway through Activin receptors as a therapeutic target of musculoskeletal disease and cancer. Endocr J , 2008; 55( 1): 11- 21.

Abdipranoto-Cowley A, Park JS, Croucher D,et al. Activin A is essential for neurogenesis following neurodegenration. Stem Cells,2009; 27( 6): 1330-1346.

Hashimoto M. Shoda A, Inous S, et al. Functional regulation of osteoblastic cells by the interction of activin-A with follistatin. J Biol Chem, 1992;267(7) ;4999-5004.

Zhu СС, Boone JQ, Jensen PA, et al. Drosophila Activin-p and the Activin-like product Dawdle function redundantly to regulate proliferation in the larval brain. Development, 2008; 135(3);513-521.

Tsuchida K.Sunada Y.Noji S.et al. Inhibitors of the TGF-beta superfamily and their clinical applications. Mini Rev Med Chem, 2006; 6 (11); 1255-1261.

Takehara-Kasamatsu Y. Tsuchida K. Nakatani M, et al. FLRG and myostatin expression in mouse heart. J Med Invest, 2007;54(3-4):276-288.

Hill JJ, Davies MV, Pearson AA, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. Biol Chem, 2002; 277 (43);40735-40741.

Zheng X,Zugates GT, Lu Z. et al. Baboon/dSmad2 TGF-beta signaling is required during late larval stage for development of adult-specific neurons. EMBO J ,2006;25(3) : 615-627.

Colak D. Mori T, Brill MS, et al. Adult neurogenesis requires Smad4-mediated bone morphogrnic protein signaling in stem cells. J Neurosci,2008;28(2);434-446.

Shoji H, Tsuchida K, Kishi H, et al. Identification and characterization of a PI)Z Protein that interacts with activin type receptors. J Biol Chem,2000;275(8) ;5485-5492.

Jenkin G, Ward J , Loose J, et al. Physiological and regula-tory roles of activin A in late pregnancy. Mol Cell Endocrinol,2001; 180(122):131-138.


Refbacks

  • There are currently no refbacks.